Leah Cohen

Safety of Concurrent Systemic Therapy and Total Skin Electron Therapy in Cutaneous T-Cell Lymphoma

Jonathan Baron, Leah Cohen, Monica Chelius, Ian Messing et autres

PURPOSE: To evaluate the safety and outcomes of total skin electron therapy (TSET) delivered with concurrent systemic therapy (CS) for cutaneous T-cell lymphoma (CTCL). METHODS: We retrospectively identified CTCL patients (including Sézary syndrome and mycosis fungoides) receiving TSET from 2013 to 2023. …

us (code pays fourni par la source)

Mycosis fungoides unmasked during lebrikizumab treatment

Isabel Yoon, Leah Cohen, Jina Chung, Ellen J. Kim

The Evolutionary Psychology of Breaking Informal Versus Formal Contracts: Effects of Group Size and Area of Upbringing

Glenn Geher, Ethan Eisenberg, Michael DeMaio, Olivia Casa et autres

The social context for human social interactions between modern urban contexts and ancestral, small-scale contexts is different in many important ways. Before the advent of agriculture, all people lived in small-scale social contexts and were surrounded by kin and other familiar others. …

us (code pays fourni par la source)

Medicare coverage of home phototherapy units for cutaneous T-cell lymphoma versus psoriasis

Leah Cohen, Oluwaseyi Adeuyan, David J. Margolis, Ellen J. Kim et autres

us (code pays fourni par la source)

Extensive Erosions and Ulcerations in a Newborn

Isabel Yoon, Leah Cohen, Corbett T. Berry, Shane M. Swink et autres

aplasia cutis congenita

us (code pays fourni par la source)

Experiences of COVID-19 Intensive Care Unit Physicians and Hospital Administrators: Qualitative Findings from Focus Groups

Traci N. Adams, Haley Belt, E. Whitney Pollio, Leah Cohen et autres

Background: While quantitative research has determined that emotional distress and psychiatric illness among frontline healthcare workers increased with the COVID-19 pandemic, detailed qualitative data describing their perso... | Find, read and cite all the research you need on Tech Science Press

us (code pays fourni par la source)

52332 Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy

Monica Chelius, Leah Cohen, John Mallon, Alain H. Rook et autres

us (code pays fourni par la source)

The chemokines CCL5 and CXCL12 exhibit high‐affinity binding to N‐terminal peptides of the non‐cognate receptors CXCR4 and CCR5 , respectively

Naama Kessler, Sabine R. Akabayov, Leah Cohen, Tali Scherf et autres

CC and CXC chemokines are distinct chemokine subfamilies. CC chemokines usually do not bind CXC‐chemokine receptors and vice versa. CCR5 and CXCR4 receptors are activated by CCL5 and CXCL12 chemokines, respectively, and are also used as HIV‐1 coreceptors. CCL5 contains one conserved …

il, us (code pays fourni par la source)

Safety of Total Skin Electron Therapy with Concurrent Systemic Therapy

Monica Chelius, Leah Cohen, Cecilia Jiang, John Mallon et autres

Introduction: Mycosis fungoides has a long, waxing and waning course. Multimodality therapy is needed to control disease. Total skin electron beam therapy (TSE) is an effective means of controlling cutaneous disease, though response duration is limited necessitating incorporation of additional therapeutics. There …

us (code pays fourni par la source)

Author response for "The chemokines CCL5 and CXCL12 exhibit high‐affinity binding to N‐terminal peptides of the non‐cognate receptors CXCR4 and CCR5 , respectively"

Naama Kessler, Sabine R. Akabayov, Leah Cohen, Tali Scherf et autres

Evaluating Photopheresis Regimens for Advanced CTCL: The Role of the SARS‐CoV‐2 Pandemic—A Single‐Center Retrospective Study

Jori Hardin, Leah Cohen, Alain H. Rook, Ellen Kim

Extracorporeal photopheresis (ECP) is an established, safe, and effective treatment for cutaneous T‐cell lymphoma (CTCL). There is no published literature reviewing the clinical efficacy of ECP at varying frequencies or the ideal duration of therapy. The SARS‐CoV‐2 pandemic necessitated a reduced frequency …

ca, us (code pays fourni par la source)

Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T‐Cell Lymphoma

David M. Weiner, Supriya Rastogi, Daniel J. Lewis, Leah Cohen et autres

Mogamulizumab is a novel monoclonal antibody designed to target CC chemokine receptor 4 (CCR4), which is expressed by tumor cells in cutaneous T‐cell lymphoma (CTCL). In clinical trials, mogamulizumab monotherapy has demonstrated efficacy in reducing tumor burden in advanced CTCL, particularly in …

us (code pays fourni par la source)